Your browser doesn't support javascript.
loading
Combination treatment strategies with a focus on rosiglitazone and adriamycin for insulin resistant liver cancer.
Dang, Yi-Fan; Yang, Shao-Hui; Jiang, Xiao-Ning; Gong, Fu-Lian; Yang, Xiao-Xia; Cheng, Yan-Na; Guo, Xiu-Li.
Afiliação
  • Dang YF; Department of Pharmacology, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, PR China.
  • Yang SH; Shandong Wendeng Osteopathic Hospital, Wendeng, PR China.
  • Jiang XN; Department of Pharmacology, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, PR China.
  • Gong FL; Department of Pharmacology, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, PR China.
  • Yang XX; Department of Pharmacology, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, PR China.
  • Cheng YN; Department of Pharmacology, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, PR China.
  • Guo XL; Department of Pharmacology, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, PR China.
J Drug Target ; 29(3): 336-348, 2021 03.
Article em En | MEDLINE | ID: mdl-33115283
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Doxorrubicina / Carcinoma Hepatocelular / Rosiglitazona / Neoplasias Hepáticas Limite: Animals / Humans / Male Idioma: En Revista: J Drug Target Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Doxorrubicina / Carcinoma Hepatocelular / Rosiglitazona / Neoplasias Hepáticas Limite: Animals / Humans / Male Idioma: En Revista: J Drug Target Ano de publicação: 2021 Tipo de documento: Article